Menu

Cancer Geneticist Quits After Harassment Allegations

Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.

Jul 17, 2018
Kerry Grens
SCREEN SHOT FROM YOUTUBE, THEICRUK

Following numerous allegations that she harassed fellow employees, Nazneen Rahman, a cancer geneticist at the Institute of Cancer Research in the U.K., will leave her post come October, The Guardian reports. Rahman had already been on administrative leave since last November.

Dozens of colleagues signed a letter last year describing bullying by Rahman. “I really had a lack of confidence in my own abilities” because of Rahman’s mistreatment, one person tells The Guardian.

The Institute of Cancer Research (ICR) commissioned an independent investigation after learning of the allegations, and when Rahman was presented with the findings, she decided to quit, ICR tells The Guardian in a statement.

“I am sorry the group feel this way,” Rahman tells The Guardian. “I want to make it clear that following the investigation there were no disciplinary findings against me. And the decision to resign was mine and mine alone.”

Nazneen’s research focused on genetic predispositions to cancer, and she has been the leader of the Division of Genetics and Epidemiology at the ICR.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
INTEGRA has responded to customers’ requests and developed two new 24-channel pipetting heads, extending the capabilities of its popular VIAFLO 96/384.
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.